Edition:
India

St. Jude Medical Inc (STJ.N)

STJ.N on New York Stock Exchange

79.64USD
23 Sep 2016
Change (% chg)

$0.03 (+0.04%)
Prev Close
$79.61
Open
$79.65
Day's High
$79.88
Day's Low
$79.44
Volume
285,205
Avg. Vol
856,849
52-wk High
$84.00
52-wk Low
$48.83

STJ.N

Chart for STJ.N

About

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement... (more)

Overall

Beta: 1.16
Market Cap(Mil.): $22,691.77
Shares Outstanding(Mil.): 284.93
Dividend: 0.31
Yield (%): 1.56

Financials

St. Jude's lawsuit against short-seller faces steep climb: lawyers

St. Jude Medical will face an uphill battle in its corporate defamation lawsuit over a short-seller's report that said the medical device company's heart implants were vulnerable to cyber attacks, lawyers familiar with such cases said.

08 Sep 2016

St. Jude's lawsuit against short-seller faces steep climb -lawyers

Sept 7 St. Jude Medical will face an uphill battle in its corporate defamation lawsuit over a short-seller's report that said the medical device company's heart implants were vulnerable to cyber attacks, lawyers familiar with such cases said.

08 Sep 2016

UPDATE 3-St. Jude sues short-seller over heart device allegations

NEW YORK/BOSTON Sept 7 St. Jude Medical Inc on Wednesday sued short-selling firm Muddy Waters and cybersecurity company MedSec Holdings Ltd, saying they intentionally disseminated false information about its heart devices to manipulate its stock.

08 Sep 2016

RPT-UPDATE 1-St. Jude sues Muddy Waters, MedSec over heart device allegations

Sept 7 St. Jude Medical Inc said on Wednesday it had filed a lawsuit against short-selling firm Muddy Waters and cyber security company MedSec Holdings Ltd alleging they intentionally disseminated false and misleading information in order to lower the value of St. Jude's stock and profit as a result.

07 Sep 2016

St. Jude sues Muddy Waters, MedSec over heart device allegations

Sept 7 St. Jude Medical Inc said on Wednesday it had filed a lawsuit against short-seller Muddy Waters and cyber security firm MedSec Holdings Ltd alleging they intentionally disseminated false and misleading information in order to lower the value of St. Jude's stock and profit as a result.

07 Sep 2016

RPT-Whiplashed investors stay skittish about St. Jude

Aug 26 One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it.

27 Aug 2016

St. Jude says report by short sellers 'false and misleading'

Medical device manufacturer St. Jude Medical Inc said on Friday a report by short-selling firm Muddy Waters and a cyber-security researcher alleging its heart devices were riddled with bugs was "false and misleading."

27 Aug 2016

Whiplashed investors stay skittish about St. Jude

One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it.St. Jude's stock at one point fell around 3 percent on Friday, though it ended the day slightly up, following a drop of around 5 percent on Thursday after Muddy Waters Capital leveled the accusation agains

27 Aug 2016

Whiplashed investors stay skittish about St. Jude

Aug 26 One day after a short seller claimed that St. Jude Medical Inc's heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs to buy it.

27 Aug 2016

Muddy Waters says St. Jude shares could fall below $55 a share: CNBC

NEW YORK Carson Block, the head of short-selling firm Muddy Waters, said on Friday that shares of medical device maker St. Jude Medical Inc could fall to $55 per share or lower if Abbott Laboratories' deal to buy the company falls apart.

27 Aug 2016

Earnings vs. Estimates